Senate Majority Leader Mitch McConnell, R-Kentucky, introduced bipartisan legislation that would raise the age to purchase tobacco-related products to 21; the US measles outbreak has surged to 880 cases this year; the FDA will end its Alternative Summary Reporting program after an investigation found that the agency had filed information regarding malfunctions of the Sprint Fidelis heart device in an internal database.
In an effort to curb the youth smoking epidemic, Senate Majority Leader Mitch McConnell, R-Kentucky, introduced bipartisan legislation that would raise the minimum age to purchase tobacco products, including vaping devices and e-cigarettes, from 18 to 21, The New York Times reported. While 14 states and 470 municipalities have already increased the age for buying tobacco-related products to 21, the use of e-cigarettes and vaping devices has continued to increase among adolescents. A government survey conducted last year found that 1 in 5 high school students in the United States reported vaping within the previous month.The US measles outbreak has resulted in 880 cases this year, the most that have occurred since 1994, with 41 new infections reported just last week, according to The New York Times. Of the new cases, 30 occurred in New York State. Measles cases have now been reported in 24 states, and a spokesperson for the CDC said it’s too early to tell if the outbreak has slowed.The FDA will end its Alternative Summary Reporting program after a recent investigation found that the agency allowed Medtronic, manufacturers of the Sprint Fidelis heart device, to file 1.1 million reports of injuries caused by the product to an internal FDA database, rather than a public-facing database, since 2016. These filings kept information about malfunctions from reaching the public, according to Kaiser Health News. The FDA has pledged to allow access to the records within weeks. The device was designed for heartbeat regulation, but in some cases, it was giving patients random electrical jolts and failing to fire during cardiac emergencies.
Urticaria Diagnosis Challenged by Overlapping Pruritic Skin Conditions
April 23rd 2025Urticaria is complicated to diagnose by its symptomatic overlap with other skin conditions and the frequent misclassification in literature of distinct pathologies like vasculitic urticaria and bullous pemphigus.
Read More
New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix
April 22nd 2025On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.
Listen
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
ACOs’ Focus on Rooting Out Fraud Aligns With CMS Vision Under Oz
April 23rd 2025Accountable care organizations (ACOs) are increasingly playing the role of data sleuths as they identify and report trends of anomalous billing in hopes of salvaging their shared savings. This mission dovetails with that of CMS, which under the new administration plans to prioritize rooting out fraud, waste, and abuse.
Read More
Urticaria Diagnosis Challenged by Overlapping Pruritic Skin Conditions
April 23rd 2025Urticaria is complicated to diagnose by its symptomatic overlap with other skin conditions and the frequent misclassification in literature of distinct pathologies like vasculitic urticaria and bullous pemphigus.
Read More
New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix
April 22nd 2025On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.
Listen
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
ACOs’ Focus on Rooting Out Fraud Aligns With CMS Vision Under Oz
April 23rd 2025Accountable care organizations (ACOs) are increasingly playing the role of data sleuths as they identify and report trends of anomalous billing in hopes of salvaging their shared savings. This mission dovetails with that of CMS, which under the new administration plans to prioritize rooting out fraud, waste, and abuse.
Read More
2 Commerce Drive
Cranbury, NJ 08512